Domperidone in Treating Patients With Gastrointestinal Disorders
Domperidone in Treating Patients With Gastrointestinal Disorders
Active, not recruiting · NCT01696734 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Domperidone in Treating Patients With Gastrointestinal Disorders | Deglutition Disorders, Digestive System Diseases, Heartburn, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting, digestive system disorder, dyskinesia of esophagus, dyspepsia, esophageal disorder, esophagitis, gastroenteritis, gastroesophageal reflux disease, gastroparesis, palsy, stomach disorder | Active, not recruiting | Phase 3 | 2026-09-24 | NCT01696734 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M D Anderson Cancer Center | Houston | United States | 667 |